Paracetamol/tramadol - Athena Drug Delivery Solutions/Novartis

Drug Profile

Paracetamol/tramadol - Athena Drug Delivery Solutions/Novartis

Alternative Names: Palitex; Paracetamol/tramadol ODT; Paracetamol/tramadol oral dispersible tablet; Paracetamol/tramadol oro-dispersible tablet; Tramadol/paracetamol oral dispersible tablet

Latest Information Update: 01 Oct 2015

Price : $50

At a glance

  • Originator Novartis
  • Developer Athena Drug Delivery Solutions
  • Class Acetanilides; Antipyretics; Cyclohexanols; Dimethylamines; Non-opioid analgesics; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists; Prostaglandin synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 01 Apr 2015 Preregistration for Pain in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top